Targeting 5-HT1A receptors in astrocytes to protect dopaminergic neurons in parkinsonian models

Neurobiology of Disease

Volumn 59, Issue , 2013, Pages 244-256

  Miyazaki, Ikuko ^a   Asanuma, Masato ^a   Murakami, Shinki ^a   Takeshima, Mika ^a   Torigoe, Nao ^a   Kitamura, Yoshihisa ^a   Miyoshi, Ko ^a,b  

^a OKAYAMA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

5 HT1A receptor; 8 OH DPAT; Astrocyte; Metallothionein; Neuroprotection; Parkinson's disease

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; APOMORPHINE; BUSPIRONE; METALLOTHIONEIN I; METALLOTHIONEIN II; OXIDOPAMINE; PROTEIN S100B; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; TRANSCRIPTION FACTOR NRF2;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DRUG DOSE COMPARISON; EMBRYO; ENRICHMENT CULTURE; FEMALE; MALE; MESENCEPHALON; MOUSE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSONISM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; STRIATONIGRAL DEGENERATION; UPREGULATION;

5-HT(1A) RECEPTOR; 8-OH-DPAT; ASTROCYTE; METALLOTHIONEIN; NEUROPROTECTION; PARKINSON'S DISEASE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENERGIC AGENTS; ANIMALS; ASTROCYTES; BRAIN; BUSPIRONE; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; FEMALE; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED ICR; OXIDOPAMINE; PARKINSON DISEASE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN RECEPTOR AGONISTS; WATER;

EID: 84883306197     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.08.003     Document Type: Article

References (29)

1. Asanuma M., et al. Attenuation of 6-hydroxydopamine-induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice. Neuroscience 1998, 85:907-917.
2. Asanuma M., et al. Neuroprotective effects of zonisamide target astrocyte. Ann. Neurol. 2010, 67:239-249.
3. Bezard E., et al. 5-HT1A receptor agonist-mediated protection from MPTP toxicity in mouse and macaque models of Parkinson's disease. Neurobiol. Dis. 2006, 23:77-86.
4. Chen P.C., et al. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: critical role for the astrocyte. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2933-2938.
5. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 2003, 60:540-551.
6. Dupre K.B., et al. Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat. Neuropharmacology 2008, 55:1321-1328.
7. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 1997, Academic Press, San Diego.
8. Heneka M.T., et al. Neuroglia in neurodegeneration. Brain Res. Rev. 2010, 63:189-211.
9. Kalia L.V., et al. Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials. Mov. Disord. 2013, 28:131-144.
10. Kaneko S., et al. Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function. Science 2000, 289:633-637.
11. Lee J.M., et al. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem. 2003, 278:12029-12038.
12. Lee H.J., et al. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J. Biol. Chem. 2010, 285:9262-9272.
13. Makar T.K., et al. Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J. Neurochem. 1994, 62:45-53.
14. Mauler F., et al. Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY×3702 in vitro and in vivo. Brain Res. 2001, 888:150-157.
15. Meissner W.G., et al. Priorities in Parkinson's disease research. Nat. Rev. Drug Discov. 2011, 10:377-393.
16. Mena M.A., Garcia de Yebenes J. Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia. Neuroscientist 2008, 14:544-560.
17. Merzak A., et al. Expression of serotonin receptors in human fetal astrocytes and glioma cell lines: a possible role in glioma cell proliferation and migration. Mol. Brain Res. 1996, 41:1-7.
18. Mignon L., Wolf W.A. Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease. Psychopharmacology 2007, 192:49-59.
19. Miyazaki I., et al. Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity. Glia 2011, 59:435-451.
20. Ohman J., et al. Repinotan (BAY×3702): a 5HT1A agonist in traumatically brain injured patients. J. Neurotrauma 2001, 18:1313-1321.
21. Radtke F., et al. Cloned transcription factor MTF-1 activates the mouse metallothionein I promoter. EMBO J. 1993, 12:1355-1362.
22. Rappold P.M., Tieu K. Astrocytes and therapeutics for Parkinson's disease. Neurotherapeutics 2010, 7:413-423.
23. Robinson M.B. The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype. Neurochem. Int. 1998, 33:479-491.
24. Rothstein J.D., et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996, 16:675-686.
25. Selinfreund R.H., et al. Neurotrophic protein S100 beta stimulates glial cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:3554-3558.
26. Shih A.Y., et al. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J. Neurosci. 2003, 23:3394-3406.
27. Vargas M.R., Johnson J.A. The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev. Mol. Med. 2009, 11:e17.
28. Whitaker-Azmitia P.M., et al. Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res. 1990, 528:155-158.
29. Whitaker-Azmitia P.M., et al. Localization of 5-HT1A receptors to astroglial cells in adult rats: implications for neuronal-glial interactions and psychoactive drug mechanism of action. Synapse 1993, 14:201-205.